Henry Schein (NASDAQ:HSIC) Raised to “Buy” at StockNews.com

Henry Schein (NASDAQ:HSICGet Rating) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday.

Several other equities analysts also recently issued reports on HSIC. Morgan Stanley reduced their price target on shares of Henry Schein from $72.00 to $70.00 and set an “underweight” rating for the company in a report on Wednesday, December 21st. Piper Sandler decreased their target price on shares of Henry Schein from $96.00 to $85.00 and set an “overweight” rating for the company in a research report on Monday, September 26th. Finally, William Blair reaffirmed a “market perform” rating on shares of Henry Schein in a report on Tuesday, November 1st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $84.44.

Henry Schein Price Performance

HSIC opened at $80.86 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.84 and a debt-to-equity ratio of 0.22. The company’s 50-day moving average price is $80.65 and its 200 day moving average price is $75.60. Henry Schein has a fifty-two week low of $64.75 and a fifty-two week high of $92.68. The firm has a market cap of $10.96 billion, a price-to-earnings ratio of 17.58, a price-to-earnings-growth ratio of 2.15 and a beta of 0.82.

Henry Schein (NASDAQ:HSICGet Rating) last posted its earnings results on Tuesday, November 1st. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.14 by $0.01. The company had revenue of $3.07 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 15.48% and a net margin of 5.06%. As a group, sell-side analysts expect that Henry Schein will post 4.81 earnings per share for the current year.

Insider Transactions at Henry Schein

In other Henry Schein news, CEO Stanley M. Bergman sold 54,216 shares of the business’s stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $81.16, for a total value of $4,400,170.56. Following the sale, the chief executive officer now directly owns 488,126 shares in the company, valued at $39,616,306.16. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Henry Schein news, CEO Stanley M. Bergman sold 54,216 shares of Henry Schein stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $81.16, for a total value of $4,400,170.56. Following the transaction, the chief executive officer now owns 488,126 shares in the company, valued at $39,616,306.16. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Bradford C. Connett sold 6,840 shares of the stock in a transaction on Wednesday, December 21st. The shares were sold at an average price of $80.71, for a total value of $552,056.40. Following the sale, the chief executive officer now owns 55,412 shares of the company’s stock, valued at approximately $4,472,302.52. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 76,397 shares of company stock valued at $6,190,246. Corporate insiders own 1.00% of the company’s stock.

Institutional Trading of Henry Schein

A number of hedge funds have recently bought and sold shares of the company. Dark Forest Capital Management LP purchased a new stake in shares of Henry Schein in the 2nd quarter valued at approximately $34,000. Ronald Blue Trust Inc. purchased a new position in shares of Henry Schein during the second quarter valued at $37,000. Ellevest Inc. raised its position in Henry Schein by 231.8% during the third quarter. Ellevest Inc. now owns 564 shares of the company’s stock valued at $37,000 after buying an additional 394 shares during the period. Venture Visionary Partners LLC purchased a new stake in Henry Schein in the 2nd quarter worth about $46,000. Finally, Guardian Wealth Advisors LLC purchased a new stake in Henry Schein in the 3rd quarter worth about $51,000. 95.45% of the stock is owned by hedge funds and other institutional investors.

Henry Schein Company Profile

(Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.